Literature DB >> 20349106

Hospital-acquired pneumonia and bacteremia caused by Legionella pneumophila in an immunocompromised patient.

C-C Lai1, C-K Tan, C-H Chou, H-L Hsu, Y-T Huang, C-H Liao, P-R Hsueh.   

Abstract

The Legionella species is an important cause of communityand hospital-acquired pneumonia. Bacteremic pneumonia caused by L. pneumophila is rarely reported. We describe the first reported case of hospital-acquired pneumonia and bacteremia caused by L. pneumophila from Taiwan in a patient with idiopathic thrombocytopenic purpura who received steroid treatment. The patient was successfully treated with ceftazidime and clindamycin initially, followed by ciprofloxacin for 14 days. The blood isolate was further confirmed by 16S rDNA sequence analysis.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20349106     DOI： 10.1007/s15010-009-9253-1

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


  9 in total

1.  Susceptibility of Legionella species to five antibiotics and development of resistance by exposure to erythromycin, ciprofloxacin, and rifampicin.

Authors:  K Nielsen; J M Bangsborg; N Høiby
Journal:  Diagn Microbiol Infect Dis       Date:  2000-01       Impact factor: 2.803

2.  Persistent Legionella pneumophila bacteraemia in an immunocompromised host.

Authors:  T F Marrie; R S Martin
Journal:  J Infect       Date:  1988-03       Impact factor: 6.072

Review 3.  Epidemiologic aspects of legionellosis.

Authors:  C V Broome; D W Fraser
Journal:  Epidemiol Rev       Date:  1979       Impact factor: 6.222

4.  Recurrent infection due to Legionella pneumophila in a patient with AIDS.

Authors:  J N Morley; L C Smith; A L Baltch; R P Smith
Journal:  Clin Infect Dis       Date:  1994-12       Impact factor: 9.079

5.  Delay in appropriate therapy of Legionella pneumonia associated with increased mortality.

Authors:  C H Heath; D I Grove; D F Looke
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-04       Impact factor: 3.267

6.  Legionella pneumophila serogroup Lansing 3 isolated from a patient with fatal pneumonia, and descriptions of L. pneumophila subsp. pneumophila subsp. nov., L. pneumophila subsp. fraseri subsp. nov., and L. pneumophila subsp. pascullei subsp. nov.

Authors:  D J Brenner; A G Steigerwalt; P Epple; W F Bibb; R M McKinney; R W Starnes; J M Colville; R K Selander; P H Edelstein; C W Moss
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

7.  Legionella pneumonia and bacteraemia in association with protein-losing enteropathy after Fontan operation.

Authors:  Y F Cheung; M P Leung; K Y Yuen
Journal:  J Infect       Date:  2001-04       Impact factor: 6.072

8.  Isolation of Legionella pneumophila from blood with the BACTEC system: a prospective study yielding positive results.

Authors:  J D Rihs; V L Yu; J J Zuravleff; A Goetz; R R Muder
Journal:  J Clin Microbiol       Date:  1985-09       Impact factor: 5.948

9.  Surveillance for Legionnaires' disease. Risk factors for morbidity and mortality.

Authors:  B J Marston; H B Lipman; R F Breiman
Journal:  Arch Intern Med       Date:  1994-11-14
  9 in total
  3 in total

1.  The Diagnosis of Legionella pneumophila Serogroup 5 Bacteremic Pneumonia during Severe Neutropenia Using Loop-mediated Isothermal Amplification.

Authors:  Shuhei Moriguchi; Masahiro Abe; Muneyoshi Kimura; Chiemi Yoshino; Masaru Baba; Chikako Okada; Koji Izutsu; Shuichi Taniguchi; Hideki Araoka; Akiko Yoneyama
Journal:  Intern Med       Date:  2017-12-21       Impact factor: 1.271

2.  Legionella Pneumonia Complicated with Acquired Fanconi Syndrome.

Authors:  Ryo Koda; Ryo Itoh; Masafumi Tsuchida; Kazumasa Ohashi; Noriaki Iino; Toshinori Takada; Ichiei Narita
Journal:  Intern Med       Date:  2018-06-06       Impact factor: 1.271

3.  The clinical presentation of Legionella arthritis reveals the mode of infection and the bacterial species: case report and literature review.

Authors:  Marine Ibranosyan; Laetitia Beraud; Hélène Lemaire; Anne-Gaëlle Ranc; Christophe Ginevra; Sophie Jarraud; Ghislaine Descours
Journal:  BMC Infect Dis       Date:  2019-10-21       Impact factor: 3.090
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.